4D MOLECULAR THERAPEUTICS IN (FDMT)

US35104E1001 - Common Stock

23.93  -0.32 (-1.32%)

After market: 23.93 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
20.72M3.13M18.04M13.61M6.99M
Operating Expenses
133.59M113.16M89.37M70.28M52.61M
Research and Development
97.10M80.25M61.36M53.04M38.72M
Selling, General, and Administrative Expenses
36.49M32.91M28.01M17.24M13.90M
Operating Income
-112.87M-110.03M-71.33M-56.66M-45.62M
Interest Income/Expense
12.21M2.57M140.00K150.00K1.50M
Other Income/Expense
-181.00K-40.00K-120.00K-180.00K-50.00K
Non Recurring Items
N/AN/AN/A0.00-5.14M
Income Before Taxes
-100.84M-107.49M-71.32M-56.69M-49.31M
Net Income
-100.84M-107.49M-71.32M-56.69M-49.31M
EBITDA
-108.66M-107.63M-69.81M-55.22M-44.62M
 
Per Share Data
EPS Diluted Total Ops
-2.58-3.32-2.57-2.12-9.38
Non GAAP EPS
-2.64-3.32-2.56N/AN/A
 
Statistics
Profit Margin
-486.59%-3434.19%-395.34%-416.53%-705.44%
Operating Profit Margin
-544.65%-3515.34%-395.40%-416.31%-652.65%

All data in USD

Charts